14 Stocks on Jim Cramer’s Radar: Nokia, Cameco, and AI Stocks’ Dip

7. Beam Therapeutics Inc. (NASDAQ:BEAM)

Beam Therapeutics Inc. (NASDAQ:BEAM) was among the stocks on Jim Cramer’s Mad Money radar as he discussed the recent sell-off in AI-related stocks. A caller asked if the stock is a buy, hold, or “forget about it,” and Cramer replied:

Oh, okay. I’ll tell you, Beam is a speculative situation. They do have some formulations. We don’t want to buy any of these stocks that are heavily shorted because they’re all, by nature, heavily shorted because they don’t have any earnings. I would buy this if you thought that they’ve got something that can save a lot of lives. That’s it. Otherwise, move on.

Beam Therapeutics Inc. (NASDAQ:BEAM) develops precision genetic medicines using base-editing technology to treat serious diseases such as sickle cell disease and liver disorders. On October 7, 2025, an Investing Club member inquired about the stock, and Cramer rejoined:

Man, you are really, that’s the speculative bottom there. I’m sorry. I would like to be more positive about that, but that one, I can’t go with. I’m sorry.

It is worth noting that since the above comment was aired, Beam Therapeutics Inc. (NASDAQ:BEAM) stock has gone up more than 21% as of April 28.